Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects - Bandyopadhyay, G K; Yu, J G; Ofrecio, J (Diabetes, 2006)
et al.